Fresh Competition Coming For Narcan In US

Amphastar Receives Approval For 505(b)(2) Naloxone As Amneal Files Generic

 
• By Dave Wallace

Further US hybrid and generic rivals to Narcan are in the works, with Amphastar having just received an FDA nod for its naloxone nasal spray in a proprietary device as Amneal files an ANDA for a further generic version.

Narcan 4mg spray
More rivals to Narcan are being approved and reviewed by the FDA • Source: Shutterstock

More from Products

More from Generics Bulletin